GSA Capital Partners’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$22K	Buy	+13,466	New	+$22K	﹤0.01%	1689
2022 Q2	–	Sell	-13,127	Closed	-$154K	–	1835
2022 Q1	$154K	Buy	13,127 +1,030	+9%	+$12.1K	0.02%	1227
2021 Q4	$222K	Buy	12,097 +6,964	+136%	+$128K	0.03%	1144
2021 Q3	$128K	Buy	+5,133	New	+$128K	0.01%	1302